Recombinant anti-IgE monoclonal antibody(Cspc Baike)
重组抗IgE单克隆抗体（石药集团百克）
Report date: 2026/05/28 20:00:21
Base Information
Drug NameRecombinant anti-IgE monoclonal antibody(Cspc Baike)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCspc Baike (Shandong) Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCspc Baike (Shandong) Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A